Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Expression of Arl6ip5 is affected by vitamin A. Additionally we are shipping ADP-Ribosylation-Like Factor 6 Interacting Protein 5 Kits (8) and ADP-Ribosylation-Like Factor 6 Interacting Protein 5 Proteins (3) and many more products for this protein.
Showing 10 out of 57 products:
Human Polyclonal Arl6ip5 Primary Antibody for ELISA, WB - ABIN184829
Lin, Orlov, Ruggiero, Dykes-Hoberg, Lee, Jackson, Rothstein: Modulation of the neuronal glutamate transporter EAAC1 by the interacting protein GTRAP3-18. in Nature 2001
Show all 2 references for ABIN184829
the JWA deficiency through cascading FAK (show PTK2 Antibodies)-PI3K-Akt (show AKT1 Antibodies)-mTOR (show FRAP1 Antibodies) pathway increases the newborn neurons.
These findings indicated that Arl6ip5 was an anti-catabolic factor by binding with RANKL (show TNFSF11 Antibodies) and disturbing its subcellular trafficking in osteoblast.
Arl6ip5 is a novel regulator of bone formation in osteoblasts.
This study provided evidence that astrocytic JWA expression protects DA neurons from degeneration and plays an important role in neuroprotection via inhibition of ROS (show ROS1 Antibodies) and NF-kappaB (show NFKB1 Antibodies) activation.
The double-fluorescent immunohistochemical analysis revealed that addicsin and TR1 (show TXNRD1 Antibodies) were coexpressed in neurons
Data show the importance of JWA (Arl6ip5) in skin homeostasis and in the process of skin tumor development.
This study demonistrated that GTRAP3-18(-/-) mice performed better in motor/spatial learning and memory tests. The suppression of GTRAP3-18 increases neuronal resistance to oxidative stress by increasing GSH content and also facilitates cognitive function
Arl6ip1 (show ARL6IP1 Antibodies) is a novel addicsin-associated partner that promotes EAAC1 (show SLC1A1 Antibodies)-mediated glutamate (show GRIN1 Antibodies) transport activity by decreasing the number of addicsin molecules available for interaction with EAAC1 (show SLC1A1 Antibodies).
98% identity with that of rat GTRAP3-18; upregulated in the amygdala by repeated administration of morphine
Addicsin mRNA is expressed in CNS neurons and may participate in the functional expression of the somatic sensory system by modulation of EAAC1 (show SLC1A1 Antibodies)-mediated glutamate (show GRIN1 Antibodies) transport.
JWA and topoisomerase II (show TOP2 Antibodies) alpha regulate each other in tumor cells arrested in G2/M.
the JWA gene may regulate human breast cancer cells through the MAPK (show MAPK1 Antibodies) signaling pathway using different types of regulation.
This review gives an overview of EAAC1 (show SLC1A1 Antibodies)-mediated GSH synthesis, and its regulatory mechanisms by GTRAP3-18 in the brain, and a potential approach against neurodegeneration.
JWA reverses cisplatin resistance via the CK2 (show CSNK2A1 Antibodies)-XRCC1 (show XRCC1 Antibodies) pathway in human gastric cancer cells.
data demonstrate that JWA plays a crucial role in HCC (show FAM126A Antibodies) progression and suggest JWA may be a potential prognostic biomarker and therapeutic target for HCC (show FAM126A Antibodies).
A significant negative correlation between JWA and ILK (show ILK Antibodies) in melanoma biopsies.
Loss of JWA expression was strongly correlated with increased gastric cancer angiogenesis.
JWA has an important role in ING4 (show ING4 Antibodies)-regulated melanoma angiogenesis, and ING4 (show ING4 Antibodies)/JWA/ILK (show ILK Antibodies) are promising prognostic markers and may be used as anti-angiogenic therapeutic targets for melanoma.
A combined effect of p53 (show TP53 Antibodies) with JWA as efficient prognostic indicators was found for the first time.
JWA plays an important role in the occurrence and progress of human esophageal squamous cell carcinoma (ESCC) and that high expression level of JWA may predict a favorable prognosis in ESCC patients.
Expression of this gene is affected by vitamin A. The encoded protein of this gene may be associated with the cytoskeleton. A similar protein in rats may play a role in the regulation of cell differentiation. The rat protein binds and inhibits the cell membrane glutamate transporter EAAC1. The expression of the rat gene is upregulated by retinoic acid, which results in a specific reduction in EAAC1-mediated glutamate transport.
ADP-ribosylation-like factor 6 interacting protein 5
, ADP-ribosylation factor-like 6 interacting protein 5
, ADP-ribosylation factor-like protein 6-interacting protein 5
, ARL-6-interacting protein 5
, PRA1 family protein 3
, glutamate transporter EAAC1-interacting protein
, prenylated Rab acceptor protein 2
, protein JWa
, PRA1 domain family 3
, cytoskeleton related vitamin A responsive protein
, cytoskeleton-related vitamin A-responsive protein
, dermal papilla derived protein 11
, dermal papilla-derived protein 11
, glutamate transporter EEAC1-associated protein
, putative MAPK activating protein PM27
, putative MAPK-activating protein PM27
, glutamate transporter EAAC1 interacting protein
, PRA1 family protein-like protein